Roger G. Stoll Ph.D., Chief Executive Officer at CORTEX PHARMACEUTICALS INC/DE/ (COR), bought 10,000 shares at $0.65 ($7K) on 2007-12-12, disclosed to the SEC on 2007-12-12.
Open-market purchase of $6k COR by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| DCTH | BUY | 2015-07-28 | $11K | — | Filing → |
| DCTH | BUY | 2009-11-20 | $90K | — | Filing → |
| DCTH | BUY | 2009-08-26 | $31K | — | Filing → |